Prostate Cancer Patients Treated by Radiotherapy
11
8
8
0
Key Insights
Highlights
No notable highlights available yet
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 75/100
9.1%
1 terminated out of 11 trials
0.0%
-86.5% vs benchmark
9%
1 trials in Phase 3/4
0%
0 of 0 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Clinical Trials (11)
SpaceOAR Post-Market Registry Study
Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria
64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer
A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec
Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial
Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer
Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy
The Effect of a Structured Strength and Endurance Training Program on Quality of Life, Fitness, Blood Parameters and Survival in Prostate Cancer Patients
Reminder App to Optimize Bladder Filling During Radiotherapy for Prostate Cancer
A Reminder App to Optimize Bladder Filling in Patients with Prostate Cancer Receiving HYPO-fractionated Radiotherapy
Post-marketing Surveillance Regarding Efficacy and Safety of SpaceOAR™